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Aims: To assess the feasibility of keeping a log of diabetes-related communication in a
community pharmacy and to explore the potential of the logs to reflect diabetes-related
communications within pharmacies. Design: A reflective log-keeping exercise (the log
designed by the researchers and provided in a booklet form) in community pharmacies of
any diabetes-related communication taking place between pharmacy staff and their ser-
vice users, and any signposting made to and from other relevant health professionals.
The study ran for four weeks. Subjects and setting: Nine community pharmacy
branches of the Independent Pharmacy Care Centres PLC based in Hull, East Yorkshire
and North & North East Lincolnshire. Outcome measures: A description of the form
and nature of diabetes-related communication, taking place within the community
pharmacy. The research team also sought feedback on the experience of keeping the log.
Results: Twenty-two communications were logged; twenty-one involved direct face-to-
face contact and one log involved a telephone conversation. Two-thirds of the communi-
cations involved conversations with patients with diabetes, a third were with a
partner/family member.  The conversations captured fell into five categories: sugar free
medicines, blood glucose-testing metre, prescription medicines, diabetes specific educa-
tion/information and an unclassified category, respectively.  The logs demonstrated that
communications can involve all members of the staff team, working independently or
jointly across their roles in the pharmacy. Conclusion: Community pharmacies in the
pilot study were actively involved in providing diabetes health-related information/educa-
tion and support. Communications involved directly assisting people with diabetes and
providing information to people supporting others with a diagnosis of diabetes. We pro-
pose that the logs provide a valuable means of acquiring information about the form and
nature of diabetes-related communication and signposting within community pharmacy.
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Introduction
This article reflects on the findings from a small
study, examining the feasibility of keeping a log
of diabetes-related communication in community
pharmacy. The study was undertaken as a precur-
sor for part of a larger research project, which aims
to explore the perceptions and experiences of com-
munity pharmacy diabetes care provision: those
of service users, their local pharmacists and other
health professionals involved in diabetes care.This
article considers the results of the feasibility study
in relation to The National Service Framework for
diabetes (DNSF, Department of Health, 2001) and
the developing role of community pharmacy in
disease management.
Diabetes is one of the most significant public
health challenges facing the UK today (Diabetes
UK, 2005). The government is now determined to
decrease the burden of diabetes across the National
Health Service (NHS) in primary care, acute hos-
pitals and community services (Department of
Health, 2001). As a life-long disorder, diabetes has
the potential significance to influence all aspects of
life from health, well-being, life expectancy, through
to lifestyle, relationships, work and income. The
effective management of diabetes can reduce com-
plications and increase life expectancy. Living with
diabetes is not straightforward: it involves personal
commitment and an active involvement with the
condition. People with diabetes manage their con-
dition on a day-to-day basis within their lifestyles
and circumstances, away from the care and instruc-
tion of health care professionals. Ninety-five per
cent of the management of diabetes is self-care
(Diabetes UK, 2005). Thus, the basis of good dia-
betes care is to empower patients to play a central
role in the management of their disorder (The
St Vincent Declaration, 1990).
The National Service Framework programme
(NSF) was established to set national standards in
the NHS in an attempt to improve service provision
and equity in care (Department of Health, 2002a).
The DNSF puts forward a long-term plan to pro-
vide better care for people with diabetes. The aim
is to care for people with diabetes using patient-
centred service models (Department of Health,
2001, 2004a). The DNSF suggests that primary
health care teams should determine the best way
of delivering the diabetes standard by considering
the proposals outlined in the Delivery Strategy in
terms of their own local circumstances and the com-
munities which they serve. At the same time, the
government is calling on pharmacists to develop
more responsive and innovative services to meet
diabetes NSF targets. With their local knowledge
of the local community, community pharmacists are
well placed to regularly interact meaningfully with
patients to deliver health promotion and medicines
use (Department of Health, 2003).
The DNSF requires pharmacists (both individu-
ally and collectively) to reconsider their role in
diabetes care in the multidisciplinary diabetes care
team. The potential of community pharmacists of
being instrumental in the implementation of the
DNSF standards and objectives is demonstrated
clearly in terms of Type 2 diabetes: community
pharmacists can dispense medication, provide in-
house medication management (including a medi-
cines use review) (Department of Health, 2003;The
Pharmaceutical Services Negotiating Committee,
2004a) and a diabetes monitoring service (includ-
ing blood glucose blood pressure, blood lipid, and
HbA1c); screen for undiagnosed diabetes; and
provide information to help people with diabetes
to understand their disorder. In their role in health
promotion, pharmacists can actively promote exer-
cise and provide advice on diet, smoking cessation
and healthy lifestyles by providing over-the-counter
counselling and various in-house programmes
(Royal Pharmaceutical Society of Great Britain,
2006). This expansion of their role could feasibly
include the proposed enhanced care for people with
diabetes.
The new NHS Community Pharmacy Contract
(The Pharmaceutical Services Negotiating Com-
mittee, 2004b) and numerous other major develop-
ments in the NHS in 2003–2004, which have been
designed to compliment each other, have wide
implications for future developments in commu-
nity pharmacy. These include, among others, the
continued devolution of central funding to Primary
Care Trusts, the agreement on the new General
Medical Services (GMS) contract for general prac-
titioners (GPs) (NHS Confederation and British
Medical Association (BMA), 2003; BMA, 2006/
2007) Medicines Management (Department of
Health, 2004b) and Chronic Disease Management
schemes (Department of Health,2002b).Pharmacists
have both the accessibility and expertise to signifi-
cantly contribute to improving medicines manage-
ment, health promotion and the self-management
of chronic disease (Department of Health, 2000,
2002b, 2003; Royal Pharmaceutical Society of Great
Britain, 2006). The new contract for community
pharmacy (Pharmaceutical Services Negotiating
Committee, 2004b) specifically requires pharmacists
to record advice given on prescribed medication and
self-care; to undertake appropriate health promo-
tion and to ‘signpost’ to other sources of help.
The Quality and Outcomes Framework (2004),
part of the new GMS contract for GPs, has stand-
ards and specific targets set for diabetes, along with
other chronic disorders. General practices are being
paid for meeting targets, including their participa-
tion in data collection of disease-related health indi-
cators, on the basis of a points system, determined
through the provision of good quality services. This
flexibility in meeting set targets creates opportun-
ities for pharmacists, who may be commissioned by
general practice to help achieve the standards set in
the contract1. Medicines Management is a major
government initiative: a strategy for the clinical,
cost-effective and safe use of medicines to ensure
that patients receive the maximum benefit from the
medicines they require, whilst also minimizing
potential harm. The primary prevention of chronic
disease management strategy also includes diabetes
as a risk factor. Self-management at an early stage
may help prevent the onset of complications and
further disability (Department of Health, 2002b).
The Department of Health is considering how
the role of pharmacy may be enhanced to improve
support for people with diabetes.The implementa-
tion of the DNSF programme in community phar-
macies will affect working practice and will require
effective organization based on best current prac-
tice.The new NSF health care standards will revise
contractual arrangements and service-planning
issues affecting community pharmacy practice.The
changes may not be easy and therefore it is import-
ant to assess whether the proposed role of the
community pharmacies in the new DNSF is work-
able, acceptable (to pharmacists and their cus-
tomers) and cost-effective at a local (and national)
level. Many of the early studies investigating the
role of community pharmacists in the management
of diabetes were either conducted in America or
hospital-based, and thus not entirely transferable
to community-based services in the UK (Cantril,
2004). Studies that have considered the pharma-
cist’s role in the management of diabetes in the
UK demonstrate that pharmacists, working as part
of a multidisciplinary team, can improve diabetes
management in patients (Coast-Senior et al., 1998;
Pickard et al., 1999; McClean et al., 2000; Bliss et al.,
2001; Rajaei-Dehkordi et al., 2003;Wermeille et al.,
2004). However, further research is required and
future interventions need to integrate evidence from
the literature on patient and pharmacist perspec-
tives on diabetes (Blenkinsopp and Hassey, 2005).
The diabetes communication log is the first part
of a three-stage study designed by the Hull & East
Riding Pharmacy Research Network (HERPRN)
and the Wolds Primary Care Research Network
(WoReN) exploring the perceptions and experi-
ences of community pharmacy in diabetes care pro-
vision: those of service users, their local pharmacists
and other health professionals involved in dia-
betes care2. The purpose of the log-keeping exer-
cise in this study is to capture the form and nature
of diabetes-related communication taking place
within the community pharmacy.
Method
Log design
The log was designed by the researchers with
the help of local community pharmacists to record
any communication related to diabetes, includ-
ing medication, advice, signposting and referrals
(‘advice’ was defined as any verbal interaction
which involved more than simply a financial trans-
action, Bissell et al., 1997). The log consisted of 30
identical double-sided pages of A4 with the fol-
lowing sections:
1) The role of the pharmacy staff member filling
in the form (tick box).
2) How the communication reported took place
(tick box), and with whom (tick box and add
details: ‘customer with diabetes’, ‘health profes-
sional’, ‘other representative’, and an ‘other’
option).
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1 For instance, pharmacists could develop enhanced services such
as smoking cessation clinics and carry out medication reviews to
challenge concordance and waste (Royal Pharmaceutical Society
of Great Britain, 2004). 2 See http://www.woren.org/projects.html
3) Whether the customer/professional had been
‘signposted/recommended’ to the pharmacy and
by whom (tick box and add details).
4) A free-text description of the communication,
how it came about and what was said by all
parties.
5) Any action taken or other result of the commu-
nication (free text).
6) Whether any written information, such as leaflets
were provided (Yes/no with details).
7) Whether the communication resulted in ‘sign-
posting’ the person concerned to another person.
(Yes/no with details)
Pre-pilot work
In preparation for the study, the authors involved
the four funded research pharmacies of the East
Riding Pharmacy Research Network for comments
and suggestions about the form and layout of the log
and its contents, and feedback on the experience of
keeping the log.
Setting
We chose to use for this pilot study a group of
independent community pharmacies based in Hull,
East Yorkshire and North Lincolnshire3. This was
in effect a convenience sample, but it represented
a range of local pharmacies, both urban and rural,
not part of a large chain, which had not previously
been involved in research, and so were more rep-
resentative of the wider community than those
engaged in the pharmacy research network.
Data collection
A letter, authorized by the Head of Operations of
the IPCC chain, was sent out to the pharmacies
involved. This explained what the feasibility study
was about, how it related to the proposed study
and their proposed role in piloting the communi-
cation log. The letter was followed a week later by
a telephone call, contacting the ‘appointed person’
in the pharmacies involved, to confirm the best
time and date of the delivery. A second letter was
sent, confirming the arrangements. Members of the
research team personally delivered the logs to the
pharmacies, explained the logs and how to com-
plete them.The logbook contained instructions, two
examples and evaluation sheets to be completed at
the end of the study.The log instructions explained
that the exercise was not intended to evaluate the
service provided by the pharmacy. Rather the log
had been specifically designed to help researchers
to gain an insight into the everyday communication
taking place in pharmacies relating to any aspect of
diabetes care.
The feasibility study was initially planned to run
for three weeks in total, but when some pharma-
cists indicated that they had not completed a suffi-
cient number of logs, we decided to continue for a
further week. Completed logs were returned to the
researchers with a prepaid stamped and addressed
envelope.
Data analysis
The diary entries were coded in relation to the
seven main questions comprising the log (listed 1–7
above). The researcher (NH) made a tally of the
number of responses that fell under each of the set
categories (questions 1, 2, 3, 6 and 7) and created
descriptive categories for the open responses (ques-
tions 3, 4, 5, 6 and 7). Some closed questions offered
the respondent an opportunity to provide further
description. For example, in question 3, where the
customer/professional was signposted to the phar-
macy (involving a yes or no response), the respond-
ent is invited to state by whom. Responses to
questions 4 and 5, reason for the communication
and the outcomes of the communication, were ini-
tially categorized from the data then collapsed into
higher order categories as they emerged. In this
article, the outcomes of communication are pre-
sented descriptively after presenting the reasons
for the communication to give the reader more
content of brief interventions in the ensuing com-
munication. For instance, not all outcomes simply
involved the sale of a new blood glucose-testing
meter (BGTM).
The contents of the logs were categorized by
NH and verified and agreed by a second researcher,
VF. The findings from the data are outlined below.
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3 Independent Pharmacy Care Centres plc (IPCC).
Findings
Twenty-two log sheets were completed over the
four-week period in nine pharmacies. The average
number of completed logs per pharmacy was two
(a range of 1–5 log sheets). The median length of
time to complete a log was 5 min, the range being
3 min to 4 h4. Whilst the regular pharmacist made
most entries, the logs demonstrated that diabetes-
related communications can involve all members
of the staff team, working independently or a jointly
across their roles in the pharmacy. Table 1 outlines
the variation of staff involved in communications
related to diabetes.
Two-thirds of the communications involved con-
versations with patients with a diagnosis of diabetes
while one-third involved a patient’s representative.
We shall return to the significance of this later.
The type of diabetes was insulin-dependent in five
instances, Type 2 (non-insulin dependent) in 13, and
in four the type was not recorded.
Twenty-one of the communications involved
direct face-to-face contact with the customer; one
involved a telephone conversation. Pharmacy staff
initiated three of the face-to-face diabetes-related
conversations by picking up on cues in conversa-
tion and by asking questions.Two of these commu-
nications involved the purchase of sugar free cough
medicines and the third involved the sale of a new
BGTM.
None of the communications logged involved
direct communication with another health profes-
sional. One customer was signposted to the phar-
macy by their GP to purchase a glucose-testing
meter.
The conversations captured fell into five cat-
egories: sugar free medicines, BGTM, prescription
medicines, diabetes specific education/information
and an unclassified category, respectively. Table 2
shows the categories of communications.
1) Sugar free medicines. These communications
included advice on: (a) Pholcodine Linctus for
partner with diabetes (a sugar free version was
purchased and this was initiated by the pharma-
cist); (b) a query about Lemsip (sugar free
alternative offered); (c) the best cough medicine
for people with diabetes; (d) cough medicine for
diabetes; (e) cough medicine (sugar free version,
conversation initiated by pharmacist); (f) a query
about sugar in Strepsils and (g) sugar free throat
lozenges (customer also worried and confused
over new diagnosis and perceived lack of infor-
mation from main health care provider).
A sugar free product was sold in all cases.
Enquiries about sugar free medicines provide
pharmacists opportunities to impart general dia-
betes health promotion. For example, one com-
munication was about controlling the intake of
sugar in their diet, another enquired about cur-
rent glucose readings, where the pharmacist sug-
gested more regular checks during periods of
illness.
2) BGTM. These were a referral by a GP to buy a
glucose-testing meter; a man seeking to purchase
a BGTM for his wife who was newly diagnosed;
seeking advice about buying a BGTM; looking
to buy batteries for new BGTM; seeking advice
about ordering new test strips for BGTM; pur-
chasing a new BGTM (conversation initiated by
pharmacist) and ordering a new insulin pen (the
customer was confused about his prescription).
Blood glucose-testing kits were sold in three of
these encounters, and a meter was exchanged in
another. Two gave information about the phar-
macy’s HbA1c monitoring scheme. One of these
logs also noted informing the patient about free
NHS prescriptions. Another included informa-
tion about how best to use the BGTM; the
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4 One log took 4 h to complete due to constant interruption.
Table 1 Variation of staff involved in communications
 Regular pharmacist (12)a
 Pharmacy technician (4)
 Counter assistant / pharmacy technician (3)
 Regular pharmacist, joint with dispenser (2)
 Locum pharmacist (1)
a Numbers in parenthesis indicating the number of logs
completed by designation.
Table 2 The categories of communication
1) Sugar-free medicines (7)a
2) BGTM (7)
3) Prescription medicines (4)
4) Diabetes specific education/information (3)
5) Unspecific (1)
a Numbers in parenthesis indicating the number of logs
completed per category of communication.
patient’s knowledge about acceptable blood
glucose levels was also checked. The remaining
three communications resulted in the pharma-
cist providing contact details of a supplier (a set
of batteries loaned to the customer meanwhile);
giving information on ordering new test strips
for BGTM and solving the confusion over a
prescription and the dispensing of the correct
insulin pen.
3) Prescription medicines. This category included
(a) a woman noting her partner’s recent change
to insulin and concerns about his alcohol intake
(the conversation took place with the pharmacists
whilst she picking up methadone for her son); (b)
a newly diagnosed patient confused about the
dosage stated on his prescription, expressing wor-
ries about his eyesight; (c) a customer seeking
more information about contents of a new pre-
scription and (d) a query as to whether partner
can drink alcohol with his new medication.
Information about insulin and diabetes was
given to the woman concerned about her hus-
band who has diabetes. She stated that she
intended to encourage her husband to take on a
healthier lifestyle. In the case of the confused
newly diagnosed patient, information was given
about new tablets and the dosage in the prescrip-
tion. Reassurance was offered along with dia-
betes-related information and the importance of
adherence to medication was stressed. Relevant
information was provided to the individual who
queried the prescription and diabetes-related
information/education was also offered. The
pharmacist advised the woman that her husband
could drink alcohol in moderation when taking
his medication. However, this advice was
expanded upon by further explanation of the
effect of alcohol on blood pressure and the impli-
cations of high blood pressure for levels of blood
glucose.
4) Diabetes specific education/information. A
woman was reassured about using flight socks
and given related information focusing on the
health risks related to diabetes and general
health advice.Another customer in conversation
with the regular pharmacist whilst dispensing a
prescription did not require any specific informa-
tion, but there was a general discussion about
diabetes.A third customer was worried about her
(diabetic) partner’s health/behaviour and change
in mood. She was given health information on
diabetes, the symptoms of diabetes were also
explained and she was advised to encourage her
husband to visit the diabetes nurse.
5) Unclassified category. This involved a lady
with diabetes who sought advice about the best
painkillers to take for her sore knee. Painkillers
were sold and relevant health information was
provided.
Three logs described the provision of written
information to patients. Information leaflets/man-
uals were provided with the BGTM on two occa-
sions, and another described an instance where the
pharmacists talked a customer through written
information on diabetes and provided an article to
take away (her husband was newly diagnosed).
Discussion
This small feasibility study captured some day-to-
day examples of the essential services outlined in
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Tell us about the communication, how it came
about, what was said by all parties, etc.
‘The customer came in with a new item on the
prescription. He was confused with the dosage
instruction given by the doctor for this hypo-
glycaemic tablet. I explained to him what the
dosage instruction means and showed him what
the BNF said as well. He is a newly diagnosed
diabetic, so I asked him if he has got another
appointment either with the surgery or diabetic
clinic to get the blood glucose measured after he
started the treatment. He is not quite sure when
but will need to go back to see the GP after a
month. Fasting glucose level is 8 mmol/L.’
What action was taken/what was the result of the
communication?
‘Customer was worried about his eye sight.
Explained to him to get his eyes checked regu-
larly should keep him up-to-date with his condi-
tion. But assured him that when treatment
started at the early stage of the condition, it
should slow down the progression of the disease.
Convinced him that he should take the tablets as
prescribed and monitor his blood glucose.’
Box 1 Example of free-text entries in
one log
the new NHS pharmacy contract (NHS Confeder-
ation, 2004).The study demonstrated that pharma-
cists were providing over-the-counter counselling
on medication, diabetes disease management,
the reduction of complications, promoting healthy
lifestyles and signposting customers (patients and
their carers), where necessary. The two essential
services, promotion of healthy lifestyles and sup-
port for self-care (Royal Pharmaceutical Society
of Great Britain, 2006), were particularly noted.
The provision of information, education and psy-
chological support that promotes self-management
is the cornerstone of diabetes care (Department of
Health, 2001).These NSFD Standards (Department
of Health, 2001) states that a significant propor-
tion of people with diabetes do not understand the
basic principles of their diabetes care. People with
diabetes require the knowledge, skills and motiv-
ation to evaluate their health risks, to appreciate how
they will benefit from changing their behaviours
or lifestyle and to act on this knowledge by engaging
in appropriate behaviours (Department of Health,
2001). Several communications logged in the current
study involved attending to confusion and concern 
in people newly diagnosed with diabetes, for whom
pharmacy staff offered reassurance and advice on
the importance of adherence to their medication
plan. It has been suggested that pharmacists are 
well placed to promote positive health behaviour
because they are often likely to be the last health
care professional to have contact with patients
prior to them taking their medication (Morrow
and Hargie, 1994; Rees, 1996). The pharmacist can
remind, reinforce and extend the education of its
customers with diabetes, evaluate individual know-
ledge of the condition and ensure treatment concord-
ance (Royal Pharmaceutical Society of Great
Britain, 2004). This role was evident in the commu-
nications logged in the current study. As Diabetes
NSF standards become incorporated in pharmacy
care service provision, pharmacists need to continue
to demonstrate this role for themselves and develop
this within local primary care communities.
The new contractual framework for community
pharmacy (The Pharmaceutical Services Negotiating
Committee, 2004a) and the recent White Paper on
Community Services (Department of Health, 2006)
provide opportunity for community pharmacists
to play a central role in delivering improvements
in primary care. The long-term conditions agenda
is one of the government’s principle initiatives.
Pharmacists aim to support self-care (of long-term
conditions) in three ways: proactive self-care, facili-
tated self-care and supported self-care (Royal
Pharmaceutical Society of Great Britain, 2006). For
pharmacists, self-care should not be just about
medicines – it is also about engaging with the pub-
lic and transforming to a patient-centred pharma-
cist role (Royal Pharmaceutical Society of Great
Britain, 2006).
In the present pilot study, participating pharma-
cists actively imparted information, education and
self-care advice about diabetes to customers in half
of the communications captured. Customers sought
advice from pharmacy staff, asking both direct and
indirect questions about diabetes management.
It is the role of pharmacy staff to reflect on and
develop these interactions further, record them
where they see fit and in the context of their work.
Feedback from one pharmacist, who provided four
log entries, highlighted that customers did not
directly look to pharmacists for advice about their
condition. She explained that the proactive
approaches by staff could be uncomfortable for
some customers because not all individuals wel-
comed unsolicited questions and comments. This
pharmacist commented that discussions of disease
states and management should be a matter of
course in pharmacy service provision.Training can
help change perceptions about offering proactive
advice for those pharmacists (and their staff) who
feel uncomfortable in this role (Department of
Health, 2005). Where opportunity and time are
available, efforts by pharmacy staff may serve to
educate the public to accept, use and experience the
pharmacy as a resource for health promotion/
education and general advice. For example, one log
described a casual conversation between a customer
and regular pharmacist where the customer did
not require any further information.The same cus-
tomer was invited to return for information should
the occasion arise in the future. Informing and invit-
ing customers to make use of services may be a
small but significant example of the DNSF aspir-
ations for wider and seamless support (in terms of
accessible information and education) that can be
offered to the local community.
The new pharmacy contract includes support
for carers, the promotion of healthy lifestyles and
support for self-care. It was clear from the logs,
that communications between pharmacy staff and
their customers not only involved assisting people
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with diabetes, but also included the provision of
information to family members of people with dia-
betes.The potential impact of supporting and edu-
cating carers about diabetes management in the
current study is encouraging. For example, after
inquiring after her husband’s change in prescrip-
tion one conversation progressed to diabetes man-
agement, and the customer said that she was going
to encourage her husband to take on a healthier
lifestyle. Showing interest and offering support and
education to patients with diabetes (and in this case
a family member) can boost motivation to help
people deal with the demands of ongoing chronic
management, and may also lead to behavioural
change and improvement (Royal Pharmaceutical
Society of Great Britain, 2004).
Signposting is an essential part of the new phar-
macy contract (Royal Pharmaceutical Society of
Great Britain, 2004; Department of Health, 2005).
This is an important component given that it has
been suggested that inaccessible and/or inadequate
care provision may impose a barrier to diabetes care
(Snoek, 2000). Community pharmacy has access
(and is accessible) to other health professionals and
thus can play a significant role in preventing and/or
improving disease outcomes by advising their cus-
tomers to consult other professionals in the diabetes
health care team. They can also direct patients to
local and national self-help groups such as patient
advice and liaison services, and Diabetes UK, and
put people in touch with personal health trainers
(Department of Health, 2005). In our study, one cus-
tomer was signposted to a diabetes nurse and two
logs noted that membership of Diabetes UK had
been advocated. It was apparent from the logs that
where more professional input was required (such
as an appointment at the diabetes clinic or the dia-
betes nurse), pharmacists checked with the patient
whether appropriate arrangements were in place, or
were in the process of being made. In this way the
patient was reminded of the significance of attend-
ing health appointments and the community phar-
macy is then experienced as part of the extended
diabetes care team. Currently there is no formal sys-
tem of referral from community pharmacy and this
may be an area worthy of further exploration.
The availability of time to engage in log keeping
was cited as a limitation to its wider use. However
the new Pharmacy Contract requires pharmacists
to record signposting, health promotion advice
and interventions related to medication (Royal
Pharmaceutical Society of Great Britain, 2004).
The log-keeping methodology allowed researchers
to gain an insight into pharmacy-based communica-
tions that they cannot readily observe. Such commu-
nications may not be amenable to observation
because they have no time boundaries, can be
unpredictable, are private (and hence require confi-
dentiality and respect) and are likely to be altered
by the presence of an observer. Whilst the data
derived from this small feasibility study was subject
to a simple content analysis, it is possible to use these
analyses to reflect on the value of log keeping in
researching (specific disease-related) communica-
tion in community pharmacy. The completed logs
helped illuminate the format and contexts within
which the diabetes-related communications took
place. Perhaps such an exercise can be used to
remind pharmacy staff and their commissioners of
the importance of what is ‘taken for granted’ in
day-to-day communications within community
pharmacy. The open format for questions 4 and 5
proved particularly useful for capturing communi-
cations within a context, particularly in recording
how the pharmacy staff-customer interactions can
develop opportunities for further/new discussion,
leading on to further brief health interventions.
The benefit of log keeping is the potential to record
events, as close as possible to when they occur (see
Box 1). Retrospective reframing is minimized.
Details may be lost in a retrospective interview and
specific detail is even more difficult to capture in a
standard questionnaire, designed to reflect upon
one’s overall practice. The open format for ques-
tions 4 and 5 allowed informants some latitude to
write about and to structure entries, as they felt
appropriate. With the above points in mind, log-
keeping periods may serve as both a record of
interactions and a reflective exercise for the phar-
macy team. One pharmacist involved stated that
the exercise was salutary in reminding her and the
pharmacy team to focus on different aspects of
their work. It is important to note that the logs
were commissioned specifically for research and
therefore were not ‘private’ documents.They were
written with the research team in mind, not as, for
instance, a self-appraisal document for reflective
practice. Perhaps as a reflective exercise, as well as
revealing what interventions pharmacists made,
recording disease specific communications would
allow respondents the opportunity to reflect upon
what they did not consider or do. For instance, it
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has been suggested that pharmacists and their
staff should play closer attention to the self-care
interventions that they undertake; they should 
ask themselves at every consultation: what step
they can take to support the patient to better self-
care (Royal Pharmaceutical Society of Great
Britain, 2006). Thus log keeping may form part of
a research process, whereby pharmacy staff
actively participate in both recording and reflect-
ing upon their own practice, individually and/or as
a team.
The recorded communications obtained in this
small pilot study provides some insight into the
day-to-day diabetes care services and support pro-
vided by community pharmacy. Such a log-keep-
ing exercise may serve to bring to the foreground,
diabetes-related communications that may be taken
as a matter of course.The study confirmed that the
logs are feasible and the information they acquire
will be a valuable component in the proposed study.
Whilst this feasibility study offers some hope that
community pharmacists are actively involved in
providing diabetes-related information/education
and self-care support to their customers, the limi-
tations of small numbers herein are acknow-
ledged. Researchers were reminded that a lot more
paperwork has been introduced under the New
Pharmacy Contract. Keeping a log becomes an
additional task within an increasing workload, and
this pressure needs to be accounted for in a larger
study or where a reflective log-keeping exercise is
undertaken as part of service development.
Conclusion
Whilst this small pilot study involved only nine
participating pharmacies, the logs do appear to be
a feasible way of acquiring information about the
form and nature of diabetes-related communica-
tion taking place within community pharmacy.The
completed logs demonstrate that the pharmacists
and staff participating in the study were actively
involved in providing diabetes-related informa-
tion/education and support to their customers.
Customers sought advice from pharmacy staff,
asking both direct and indirect questions about
diabetes management. Communications involved
directly assisting people with diabetes and the pro-
vision of information to people supporting those
with a diagnosis of diabetes. The conversations
captured fell into five categories: sugar free medi-
cines, BGTM, prescription, diabetes specific educa-
tion/information and an unclassified category,
respectively. The logs demonstrate that communi-
cations can involve all members of the staff team,
working independently or jointly across their roles
in the pharmacy.
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